ES2107650T3 - Derivado de 22-oxacolecalciferol y su procedimiento de produccion. - Google Patents

Derivado de 22-oxacolecalciferol y su procedimiento de produccion.

Info

Publication number
ES2107650T3
ES2107650T3 ES93900419T ES93900419T ES2107650T3 ES 2107650 T3 ES2107650 T3 ES 2107650T3 ES 93900419 T ES93900419 T ES 93900419T ES 93900419 T ES93900419 T ES 93900419T ES 2107650 T3 ES2107650 T3 ES 2107650T3
Authority
ES
Spain
Prior art keywords
different
oxacolecalciferol
derivative
rent
production procedure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93900419T
Other languages
English (en)
Spanish (es)
Inventor
Masahiro Kato
Tetsuhiro Mikami
Kiyoshige Ochi
Hiroyoshi Watanabe
Noboru Kubodera
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chugai Pharmaceutical Co Ltd
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Application granted granted Critical
Publication of ES2107650T3 publication Critical patent/ES2107650T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C401/00—Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
    • A61P5/12—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH for decreasing, blocking or antagonising the activity of the posterior pituitary hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/0065—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by an OH group free esterified or etherified
    • C07J7/007—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by an OH group free esterified or etherified not substituted in position 17 alfa
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0036—Nitrogen-containing hetero ring
    • C07J71/0042—Nitrogen only

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Nutrition Science (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
ES93900419T 1991-12-18 1992-12-18 Derivado de 22-oxacolecalciferol y su procedimiento de produccion. Expired - Lifetime ES2107650T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP36105191 1991-12-18

Publications (1)

Publication Number Publication Date
ES2107650T3 true ES2107650T3 (es) 1997-12-01

Family

ID=18471985

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93900419T Expired - Lifetime ES2107650T3 (es) 1991-12-18 1992-12-18 Derivado de 22-oxacolecalciferol y su procedimiento de produccion.

Country Status (12)

Country Link
US (1) US5436401A (enFirst)
EP (1) EP0619304B1 (enFirst)
JP (1) JP3493037B2 (enFirst)
KR (1) KR100247214B1 (enFirst)
AT (1) ATE157966T1 (enFirst)
DE (1) DE69222183T2 (enFirst)
DK (1) DK0619304T3 (enFirst)
ES (1) ES2107650T3 (enFirst)
GR (1) GR3025468T3 (enFirst)
SG (1) SG78265A1 (enFirst)
TW (1) TW222621B (enFirst)
WO (1) WO1993012083A1 (enFirst)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3563310D1 (en) * 1985-07-30 1988-07-21 Salzgitter Ind Method and device for the preparation of suspensions with constant indications from basic materials with variable properties
US6121469A (en) 1993-12-23 2000-09-19 The Regents Of The University Of California Therapeutically effective 1α,25-dihydroxyvitamin D3 analogs
US6103709A (en) * 1993-12-23 2000-08-15 The Regents Of The University Of California Therapeutically effective 1α,25-dihydroxyvitamin D3 analogs and methods for treatment of vitamin D diseases
ES2181773T3 (es) * 1994-04-19 2003-03-01 Chugai Pharmaceutical Co Ltd Productos destinados al tratamiento de la cquexia asociada con tumores.
GB9607034D0 (en) * 1996-04-03 1996-06-05 Leo Pharm Prod Ltd Chemical compounds
JP3310301B2 (ja) * 1996-09-03 2002-08-05 ザ・トラスティーズ・オブ・コロンビア・ユニバーシティ・イン・ザ・シティ・オブ・ニューヨーク ビタミンｄおよびステロイド誘導体の合成用中間体およびその製造方法
GB9804861D0 (en) 1998-03-06 1998-04-29 Res Inst Medicine Chem Chemical compounds
CN1150973C (zh) 1998-07-03 2004-05-26 中外制药株式会社 光化学反应用紫外线照射装置以及使用它的维生素d衍生物的制备方法
DE60044090D1 (de) * 1999-08-27 2010-05-12 Hiroaki Takayama Vitamin-d-derivate mit substituenten an der 2-alpha-position
JP4803939B2 (ja) 2000-04-19 2011-10-26 中外製薬株式会社 ビタミンｄ誘導体
CN100469764C (zh) * 2000-06-15 2009-03-18 中外制药株式会社 维生素d衍生物
CN1449289A (zh) * 2000-08-30 2003-10-15 中外制药株式会社 Oct制剂
JP2014514274A (ja) 2011-03-09 2014-06-19 テバ ファーマシューティカル インダストリーズ リミティド マキサカルシトールの多形およびマキサカルシトールの調製方法
CN102796134B (zh) * 2012-08-31 2015-07-01 甘肃皓天化学科技有限公司 一种马沙骨化醇中间体的制备方法
CN103508999B (zh) 2013-10-12 2015-05-13 浙江海正药业股份有限公司 马沙骨化醇的合成中间体及其制备方法和用途
CN107286067A (zh) * 2016-04-05 2017-10-24 湖南华腾制药有限公司 一种马沙骨化醇的制备方法
CN114728874B (zh) 2019-11-27 2024-04-26 研成精密化学株式会社 用于制备马沙骨化醇的方法及用于其的中间体

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61140560A (ja) * 1984-12-12 1986-06-27 Chugai Pharmaceut Co Ltd ２０−オキサ−２１−ノルビタミンｄ３誘導体
JPS61267550A (ja) * 1984-12-28 1986-11-27 Chugai Pharmaceut Co Ltd ９，１０−セコ−５，７，１０（１９）−プレグナトリエン誘導体
JP3050564B2 (ja) * 1989-12-15 2000-06-12 中外製薬株式会社 新規な２２―オキサビタミンｄ誘導体

Also Published As

Publication number Publication date
WO1993012083A1 (fr) 1993-06-24
DK0619304T3 (da) 1998-02-16
ATE157966T1 (de) 1997-09-15
TW222621B (enFirst) 1994-04-21
JP3493037B2 (ja) 2004-02-03
GR3025468T3 (en) 1998-02-27
DE69222183D1 (de) 1997-10-16
EP0619304A4 (en) 1995-03-29
DE69222183T2 (de) 1998-01-22
EP0619304B1 (en) 1997-09-10
JPH0672994A (ja) 1994-03-15
HK1002729A1 (en) 1998-09-11
KR100247214B1 (ko) 2000-03-15
SG78265A1 (en) 2001-02-20
EP0619304A1 (en) 1994-10-12
US5436401A (en) 1995-07-25
KR940703807A (ko) 1994-12-12

Similar Documents

Publication Publication Date Title
ATE163929T1 (de) Teilsynthese von taxanderivaten mittels metallalkoxiden und oxazinonen
ES2160237T3 (es) O-carbamoil-fenilalaninol que tiene sustituyente en anillo de benceno, sus sales farmaceuticamente utiles, y metodo para la preparacion de los mismos.
ES8801643A1 (es) Un metodo para producir nuevos derivados del acido ascorbico
MX9703351A (es) Esteres 2-cianoacrilicos.
DE69222183D1 (de) 22-oxacholecalziferol-derivate und ihre herstellung
ATE137238T1 (de) Beta-lactamantibiotika, verfahren zur herstellung und ihre verwendung als und in arzneimitteln
IT1164821B (it) Benzammidi eterocicliche sostituite procedimento per la loro produzione e loro impiego come modificatori di comportamento
ES2111572T3 (es) Nuevo derivado de benzopirano.
ATE18054T1 (de) Derivate und reduktionsprodukte der dglucopyranosyl-alpha(1-5)-d-arabonsaeure, deren herstellung und verwendung.
IL61285A (en) 2-hydroxyalkyl-3,4,5-trihydroxy-piperidine compounds,their production and pharmaceutical compositions containing them
ATE57703T1 (de) Verfahren zur herstellung von 2,6-substituierten 9-(1,3-dihydroxy-2-propoxymethyl)-purinen und einige derivate.
ES8600255A1 (es) Un metodo de preparar fenilalquil(piperazinil u homopiperazinil)propil-(ureas o tioureas)sustituidas
ES2056639T3 (es) Procedimiento para la transformacion del acido (benzoil-3 fenil)-2 propionico-r(-) en isomero s(+).
ES2108977T3 (es) Derivados del acido hidroximetilfurazanocarboxilico y su utilizacion en el tratamiento de enfermedades cardiovasculares.
GB925538A (en) Improvements in or relating to trifluoromethylthiaxanthene and -xanthene derivatives
BR8101541A (pt) Processo para produzir uma amina heterociclica
GB1494825A (en) Process for the production of 2-aryl-2h-benzotriazoles
ES2053632T3 (es) Piridiletanolaminas substituidas, procedimientos para su fabricacion y su utilizacion como promotores de la produccion en animales.
GB1494824A (en) Process for the production of 2-aryl-2h-benzotriazoles
HUT62564A (en) Process for producing 1-alkyl-, 1-alkenyl-, 1-alkinyl- and 1-alkinylaryl-2-amino-1,3-propanedioles, their derivatives and salts, as well as pharmaceutical compositions comprising same
ES2108261T3 (es) Derivados 2-aminoazucar de macrolidos.
ES2078431T3 (es) Derivados de tetralina y cromano para el tratamiento de asma, artritis y enfermedades relacionadas.
ES2144508T3 (es) Derivados de 2,3-dihidrobenzofurano.
BR8001208A (pt) Processo para a producao de uretanas
ES2157331T3 (es) Procedimiento de produccion de un derivado de indolocarbazol.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 619304

Country of ref document: ES